Subtopic Deep Dive

Autologous Chondrocyte Implantation
Research Guide

What is Autologous Chondrocyte Implantation?

Autologous Chondrocyte Implantation (ACI) is a two-stage cell therapy where a patient's own chondrocytes are harvested, expanded in culture, and implanted into cartilage defects to regenerate hyaline-like tissue.

ACI treats focal chondral and osteochondral defects in the knee, often in early osteoarthritis. Matrix-induced ACI (MACI) uses scaffolds like porcine collagen for better cell retention (Bartlett et al., 2005, 728 citations). Long-term studies show 70-80% good to excellent outcomes at 10-20 years (Peterson et al., 2010, 679 citations). Over 20 clinical trials compare ACI to microfracture.

15
Curated Papers
3
Key Challenges

Why It Matters

ACI provides durable repair for knee osteoarthritis patients under 50 with isolated defects, delaying total knee arthroplasty. Characterized chondrocyte implantation outperformed microfracture in structural repair and KOOS scores at 2 years (Saris et al., 2008, 647 citations). Wakitani et al. (2002, 958 citations) demonstrated feasibility in osteoarthritic knees using bone marrow cells, influencing patient selection guidelines. Bhosale and Richardson (2008, 702 citations) highlight ACI's role in longevity of cartilage repair.

Key Research Challenges

Graft Hypertrophy Risk

Early ACI techniques using periosteum covers caused hypertrophy in 20-30% of cases. Matrix-induced variants reduced this but require monitoring (Bartlett et al., 2005). Peterson et al. (2010) report 5-10% hypertrophy at long-term follow-up.

Tissue Integration Failure

Poor bonding between implant and native cartilage leads to delamination. Saris et al. (2008) found better integration with characterized cells versus microfracture. Scaffold optimization remains critical (Bartlett et al., 2005).

Optimal Patient Selection

ACI suits young patients with focal defects but outcomes vary in osteoarthritis. Wakitani et al. (2002) showed benefits in mild OA knees. Goldring and Marcu (2009) emphasize homeostasis factors influencing success.

Essential Papers

1.

Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees

Shigeyuki Wakitani, K. Imoto, Tetsuya Yamamoto et al. · 2002 · Osteoarthritis and Cartilage · 958 citations

2.

Osteoarthritis: pathogenic signaling pathways and therapeutic targets

Qing Yao, Xiaohao Wu, Chu Tao et al. · 2023 · Signal Transduction and Targeted Therapy · 925 citations

3.

Intra‐Articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritis of the Knee: A Proof‐of‐Concept Clinical Trial

Chris Hyunchul Jo, Young Gil Lee, Won Hyoung Shin et al. · 2014 · Stem Cells · 886 citations

Mesenchymal stem cells (MSCs) are known to have a potential for articular cartilage regeneration. However, most studies focused on focal cartilage defect through surgical implantation. For the trea...

4.

Cartilage homeostasis in health and rheumatic diseases

Mary B. Goldring, Kenneth B. Marcu · 2009 · Arthritis Research & Therapy · 741 citations

5.

Recent Updates of Diagnosis, Pathophysiology, and Treatment on Osteoarthritis of the Knee

Sun‐Hee Jang, Ki-Jun Lee, Ji Hyeon Ju · 2021 · International Journal of Molecular Sciences · 736 citations

Osteoarthritis (OA) is a degenerative and chronic joint disease characterized by clinical symptoms and distortion of joint tissues. It primarily damages joint cartilage, causing pain, swelling, and...

6.

Autologous chondrocyte implantation <i>versus</i> matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee

Will Bartlett, John Skinner, Christopher R. Gooding et al. · 2005 · Journal of Bone and Joint Surgery - British Volume · 728 citations

Autologous chondrocyte implantation (ACI) is used widely as a treatment for symptomatic chondral and osteochondral defects of the knee. Variations of the original periosteum-cover technique include...

7.

Articular cartilage: structure, injuries and review of management

A Bhosale, JB Richardson · 2008 · British Medical Bulletin · 702 citations

The success of any treatment lies in its longevity. The new minimally invasive techniques are being invented. However, timely research, on the basis of randomized controlled trial comparing differe...

Reading Guide

Foundational Papers

Start with Wakitani et al. (2002, 958 citations) for early autologous cell therapy in OA knees, then Bartlett et al. (2005, 728 citations) for ACI vs. MACI techniques, and Peterson et al. (2010, 679 citations) for long-term durability evidence.

Recent Advances

Study Saris et al. (2008, 647 citations) for characterized ACI superiority over microfracture, and Jo et al. (2014, 886 citations) for MSC injection comparisons in generalized OA.

Core Methods

Core techniques: chondrocyte harvest via arthroscopy, monolayer culture expansion, scaffold seeding (MACI), periosteal patching, or fibrin glue fixation (Bartlett et al., 2005; Peterson et al., 2010).

How PapersFlow Helps You Research Autologous Chondrocyte Implantation

Discover & Search

Research Agent uses searchPapers('Autologous Chondrocyte Implantation knee osteoarthritis RCT') to find 50+ trials, then citationGraph on Wakitani et al. (2002, 958 citations) reveals foundational citations branching to MACI studies. findSimilarPapers expands to Saris et al. (2008) for microfracture comparisons; exaSearch uncovers unpublished trial data.

Analyze & Verify

Analysis Agent applies readPaperContent on Peterson et al. (2010) to extract 20-year KOOS outcomes, verifies claims with CoVe against Bartlett et al. (2005), and runs PythonAnalysis to meta-analyze GRADE-graded evidence from 10 ACI trials using pandas for survival rates and matplotlib for defect size correlations.

Synthesize & Write

Synthesis Agent detects gaps like long-term OA progression post-ACI, flags contradictions between Wakitani (2002) and Jo (2014) on cell sources. Writing Agent uses latexEditText for methods sections, latexSyncCitations for 20 references, latexCompile for trial comparison tables, and exportMermaid for ACI vs. microfracture outcome flowcharts.

Use Cases

"Run meta-analysis of KOOS scores from ACI vs microfracture RCTs in knee OA"

Research Agent → searchPapers + citationGraph → Analysis Agent → readPaperContent (Saris 2008, Peterson 2010) → runPythonAnalysis (pandas meta-analysis, GRADE scoring) → CSV export of pooled effect sizes with 95% CIs.

"Draft LaTeX review section on MACI techniques and outcomes"

Synthesis Agent → gap detection on Bartlett 2005 → Writing Agent → latexEditText (insert outcomes) → latexSyncCitations (20 refs) → latexCompile → PDF with integrated KOOS meta-plots.

"Find code for ACI patient selection models from papers"

Research Agent → paperExtractUrls (Wakitani 2002) → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis (test selection algorithms on demo OA datasets) → exportMermaid (decision tree diagram).

Automated Workflows

Deep Research workflow scans 50+ ACI papers via searchPapers, structures report with GRADE tables comparing Wakitani (2002) to Saris (2008). DeepScan's 7-steps verify hypertrophy rates across Peterson (2010) and Bartlett (2005) with CoVe checkpoints. Theorizer generates hypotheses on scaffold integration from Goldring (2009) homeostasis mechanisms.

Frequently Asked Questions

What defines Autologous Chondrocyte Implantation?

ACI harvests knee cartilage cells, cultures them for 3-4 weeks, then implants under periosteum or matrix scaffold for defect repair (Peterson et al., 2010).

What are key methods in ACI research?

Original ACI uses periosteum cover; MACI employs collagen scaffolds (Bartlett et al., 2005). Characterized ACI selects optimal cells for better repair (Saris et al., 2008).

What are seminal papers on ACI?

Wakitani et al. (2002, 958 citations) pioneered bone marrow cell use in OA knees. Peterson et al. (2010, 679 citations) report 20-year outcomes; Saris et al. (2008, 647 citations) beat microfracture.

What open problems exist in ACI?

Challenges include hypertrophy reduction, seamless integration, and expanding to multifocal OA defects beyond focal lesions (Bartlett et al., 2005; Goldring and Marcu, 2009).

Research Osteoarthritis Treatment and Mechanisms with AI

PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:

Start Researching Autologous Chondrocyte Implantation with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.